NSP7 Molecular Degrader Attenuates Coronaviral Infection Through the β‐TrCP1/FBXO5 Axis
Advanced Science · 2025
DOI: 10.1002/advs.202500798 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Yao Tong und 18 weiteren Autor:innen. Beteiligte Einrichtung: Aging Institute, University of Pittsburgh/UPMC, Pittsburgh, PA, 15219, USA. Hauptthemen laut MEDLINE: Viral Nonstructural Proteins, beta-Transducin Repeat-Containing Proteins, F-Box Proteins, SARS-CoV-2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, Foundation for the National Institutes of Health, NHLBI NIH HHS.
Abstract (Originalsprache)
NSP7 (Non‐Structural Protein 7) of SARS‐CoV‐2 is a crucial component for viral replication and transcription. In this study, it is revealed that the host E3 ubiquitin ligase FBXO5 suppresses viral replication by mediating NSP7 lysine‐48‐linked ubiquitination and subsequent proteasomal degradation. Interestingly, it is also determined that NSP7 expression impairs the host antiviral response by inhibiting the ISGylation of melanoma differentiation‐associated protein 5 (MDA5), a key sensor for viral RNA. Through an unbiased esiRNA screen, it is identified that NSP7 ubiquitination is coregulated by β‐TrCP1 and the kinase TAF1. Additionally, this study uncovers a small molecule FBXO5 stabilizer that disrupts the β‐TrCP1–FBXO5 interaction, thereby markedly enhancing NSP7 degradation and effectively mitigating SARS‐CoV‐2 infection. Taken together, the findings reveal a novel mechanism for NSP7 regulation and suggest that small‐molecule activators of the E3 ubiquitin ligase FBXO5 represent a promising new class of host‐directed antiviral therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Aging Institute, University of Pittsburgh/UPMC, Pittsburgh, PA, 15219, USA.
- Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Acute Lung Injury Center of Excellence, University of Pittsburgh, Pittsburgh, PA, 15213, USA.
- Department of Infectious Diseases and Microbiology, School of Public Health, University of Pittsburgh, Pittsburgh, PA, 15213, USA.
- Department of Medicine, Division of Cardiology, University of Pittsburgh, Pittsburgh, PA, 15213, USA.
ORCID-Profile: Yao Tong, Bill B Chen
Förderung
- NIA NIH HHS
- Foundation for the National Institutes of Health
- NHLBI NIH HHS
- University of Pittsburgh Aging Institute Seed Fund
- American Heart Association
- Hevolution Foundation
- NIAID NIH HHS
- Jewish Healthcare Foundation
Zitieren
APA
Tong, Y., Lear, T. B., Tuncer, F., Villandre, J. J., Boudreau, Á. N., Lin, B., Alfaras, I., Kennerdell, J. R., Camarco, D. P., Larsen, M. B., Hua, Y., Chen, Y., Chandler, M. E., Pineda, R., Barratt-Boyes, S. M., Evankovich, J. W., Finkel, T., Liu, Y., & Chen, B. B. (2025). NSP7 Molecular Degrader Attenuates Coronaviral Infection Through the β‐TrCP1/FBXO5 Axis. Advanced Science. https://doi.org/10.1002/advs.202500798
Vancouver
Tong Y, Lear TB, Tuncer F, Villandre JJ, Boudreau ÁN, Lin B, et al. NSP7 Molecular Degrader Attenuates Coronaviral Infection Through the β‐TrCP1/FBXO5 Axis. Advanced Science. 2025. doi:10.1002/advs.202500798
BibTeX
@article{Tong2025,
author = {Tong, Yao and Lear, Travis B and Tuncer, Ferhan and Villandre, John J and Boudreau, Áine N and Lin, Bo and Alfaras, Irene and Kennerdell, Jason R and Camarco, Daniel P and Larsen, Mads B and Hua, Yun and Chen, Yanwen and Chandler, Meigin E and Pineda, Ricardo and Barratt-Boyes, Simon M and Evankovich, John W and Finkel, Toren and Liu, Yuan and Chen, Bill B},
title = {NSP7 Molecular Degrader Attenuates Coronaviral Infection Through the β‐TrCP1/FBXO5 Axis},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202500798}
}
EUVIMED